All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | TCR Clone | Host Species | Epitope | Allele | Vector Type | Inquiry & Datasheet |
TCR-YC0209 | Human anti-C43H81O13P T cell receptor (PG10), pCDTCR1 | PG10 | Human | 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoinositol (ammonium salt) | human CD1b | Lentiviral vector | ||
TCR-YC0210 | Human anti-C43H81O13P T cell receptor (PG90), pCDTCR1 | PG90 | Human | 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoinositol (ammonium salt) | human CD1b | Lentiviral vector | ||
TCR-YC0211 | Mouse anti-C43H81O13P T cell receptor (Vα14i), pCDTCR1 | Vα14i | Mouse | 1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-D-myo-inositol | mouse CD1d | Lentiviral vector |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION